Previously, the authors showed that the application of the aminodihydrophthalazinedione sodium (ADPS) immunomodulator transdermal therapeutic system (TTS) to laboratory animals provides bioavailability analogous to the intramuscular administration of this drug at the same dose. At the same time, its maximum blood concentration is significantly reduced, and the retention time of the drug in the body is increased more than 10-fold, which can contribute to prolonging the drug effect. The aim of the work was to identify a possible positive effect of the transdermal administration of the ADPS immunomodulator on reparative liver regeneration on an experimental model of extensive liver resection (ELR). It has been shown that at a period of 48 h after ELR, the percutaneous administration of the immunomodulator has a pronounced stimulating effect on the mitotic activity of rat liver cells; by 72 h after ELR, an accelerated rate of recovery of hepatic homeostasis in the body was observed in laboratory animals in groups with the application of the ADPS TTS versus the control group.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051983 | PMC |
http://dx.doi.org/10.3390/life13030658 | DOI Listing |
Objective: To evaluate the effectiveness of the drug aminodihydrophthalazinedione sodium (Galavit) for the prevention of the development of additional purulent-septic complications associated with a reduced reactivity in patients with peritonitis.
Material And Methods: Patients diagnosed with peritonitis were included in a prospective, non-randomized, single-centre study. Two groups of patients were formed, the main and control, 30 people each.
Life (Basel)
February 2023
The Shumakov National Medical Research Center of Transplantology and Artificial Organs, 1 Shchukinskaja St., 123182 Moscow, Russia.
Aim to determine the efficacy of drug aminodihydrophthalazinedione sodium (Galavit) for prevention of progression of the coronavirus infection pulmonary complications: acceleration of regression of pulmonary infiltrates and resolution of COVID-induced pneumonia. 22 patients with medium and severe COVID-induced pneumonia were included in the study. The study included 8 men and 14 women, the average age was 62.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!